Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Autor: Clamp AR; Department of Medical Oncology, The Christie National Health Service Foundation Trust, and University of Manchester, Manchester, UK., James EC; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK. Electronic address: e.james@ucl.ac.uk., McNeish IA; Department of Surgery and Cancer, Imperial College London, London, UK., Dean A; Oncology Department, St John of God Hospital, Subiaco, WA, Australia., Kim JW; Department of Obstetrics and Gynaecology, Seoul National University, Seoul, Korea., O'Donnell DM; Cancer Trials Ireland, Dublin, Ireland., Hook J; St James' University Hospital, Leeds, UK., Coyle C; Queen Alexandra Hospital, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK., Blagden S; Churchill Hospital, University of Oxford, Oxford, UK., Brenton JD; Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Cambridge, UK., Naik R; Gynaecology Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK., Perren T; St James' University Hospital, Leeds, UK., Sundar S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK., Cook AD; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK., Gopalakrishnan GS; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK., Gabra H; Department of Surgery and Cancer, Imperial College London, London, UK; Early Clinical Development, AstraZeneca, Cambridge, UK., Lord R; Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK., Dark G; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Earl HM; Department of Medical Oncology, Addenbrooke's Hospital, Cambridge, UK., Hall M; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., Banerjee S; Gynaecological Unit, The Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, London, UK., Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK., Jones R; Velindre Cancer Centre, Wales, UK., Williams S; Birmingham City Hospital, Birmingham, UK., Swart AM; Norwich Medical School, University of East Anglia, Norwich, UK., Stenning S; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK., Parmar M; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK., Kaplan R; Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials & Methodology, University College London, London, UK., Ledermann JA; University College London Cancer Institute, and University College London Hospitals, London, UK.

Publikováno v: Lancet (London, England) [Lancet] 2019 Dec 07; Vol. 394 (10214), pp. 2084-2095. Date of Electronic Publication: 2019 Nov 29.

Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes.

Autor: Dushay J; Department of Medicine, Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.jdushay@bidmc.harvard.edu, Gao C, Gopalakrishnan GS, Crawley M, Mitten EK, Wilker E, Mullington J, Maratos-Flier E

Publikováno v: Diabetes care [Diabetes Care] 2012 Jan; Vol. 35 (1), pp. 4-11. Date of Electronic Publication: 2011 Oct 31.

Loss of otolith function with age is associated with increased postural sway measures.

Autor: Serrador JM; Harvard Medical School, Boston, MA, United States; Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. serrador@hms.harvard.edu, Lipsitz LA, Gopalakrishnan GS, Black FO, Wood SJ

Publikováno v: Neuroscience letters [Neurosci Lett] 2009 Nov 06; Vol. 465 (1), pp. 10-5. Date of Electronic Publication: 2009 Aug 27.